Authors:
ROBAK T
GORATYBOR J
KRYKOWSKI E
WALEWSKI JA
BORAWSKA A
PLUZANSKA A
POTEMSKI P
HELLMANN A
ZAUCHA JM
KONOPKA L
CEGLAREK B
DURZYNSKI T
SIKORSKA A
MICHALAK K
URASINSKI J
OPALINSKA J
DMOSZYNSKA A
ADAMCZYKCIOCH MB
KURATOWSKA Z
DWILEWICZTROJACZEK J
BOGURADZKI P
DEREN M
MAJ S
GRIEB P
Citation: T. Robak et al., ACTIVITY OF 2-CHLORODEOXYADENOSINE (CLADRIBINE) IN 2-HOUR INTRAVENOUS-INFUSION IN 94 PREVIOUSLY TREATED PATIENTS WITH LOW-GRADE NON-HODGKINS-LYMPHOMA, Leukemia & lymphoma, 26(1-2), 1997, pp. 99-105
Authors:
ROBAK T
BLASINKAMORAWIEC M
KRYKOWSKI E
KASZNICKI M
PLUZANSKA A
POTEMSKI P
HELLMANN A
ZAUCHA JM
LEWANDOWSKI K
DMOSZYNSKA A
HANSZ J
KOMARNICKI M
KONOPKA I
DURZYNSKI T
CEGLAREK B
SIKORSKA A
KOTLAREKHAUS S
MAZUR G
URASINSKI I
ZDZIARSKA B
MAJ S
KOPEC I
SKOTNICKI AB
DWILEWICZTROJACZEK J
KURATOWSKA Z
GRIEB P
Citation: T. Robak et al., INTERMITTENT 2-HOUR INTRAVENOUS INFUSIONS OF 2-CHLORODEOXYADENOSINE IN THE TREATMENT OF 110 PATIENTS WITH REFRACTORY OR PREVIOUSLY UNTREATED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Leukemia & lymphoma, 22(5-6), 1996, pp. 509-514
Citation: E. Chmielowska et al., 3-DRUG COMBINATION OF CISPLATIN, DACARBAZINE, AND TAMOXIFEN IN METASTATIC MALIGNANT-MELANOMA, Journal of clinical oncology, 13(8), 1995, pp. 2146-2147